Literature DB >> 20714118

Interaction of kisspeptin and the somatotropic axis.

B K Whitlock1, J A Daniel, R R Wilborn, H S Maxwell, B P Steele, J L Sartin.   

Abstract

Kisspeptin, a regulator of gonadotropin-releasing hormone, has been hypothesized as an integrator of nutrition and hormones critical to metabolism and the regulation of reproduction. Growth hormone (GH) is necessary for optimal reproduction and recent evidence suggests that its secretion may be influenced by kisspeptin. The objectives of this study were to determine whether the effect of kisspeptin to stimulate GH release is due to an interaction with growth hormone-releasing hormone (GHRH) or somatostatin (SS), or an effect at the hypothalamus. Intravenous injection and infusion of kisspeptin [500 pmol/kg BW (650 ng/kg)/h × 5 h] to cows (n = 5) increased serum concentrations of luteinizing hormone (LH) but not GH. Pretreatment with kisspeptin injection and infusion in cows (n = 5) reduced the stimulatory effect of GHRH (0.05 μg/kg BW) on GH secretion. However, the magnitude of the GH response to GHRH (assessed by incremental AUC) was not affected by kisspeptin. In these same cows, administration of kisspeptin prevented the increase in GH induced by SS infusion (0.5 μg/kg BW/ h × 1.5 h) withdrawal. Peripheral administration of kisspeptin [200 and 1,000 pmol/kg BW (260 and 1,300 ng/kg)] increased serum concentrations of LH but not GH in ewes (n = 8). However, concentrations of GH were stimulated by central kisspeptin treatment [100 and 200 pmol/kg BW (130 and 260 ng/kg)] in ewes. In addition to activating the gonadotropic axis, kisspeptin can activate the somatotropic axis in ruminants. Present data support the concept of a central site of action for this effect.
Copyright © 2010 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20714118     DOI: 10.1159/000318049

Source DB:  PubMed          Journal:  Neuroendocrinology        ISSN: 0028-3835            Impact factor:   4.914


  7 in total

1.  ERα Signaling in GHRH/Kiss1 Dual-Phenotype Neurons Plays Sex-Specific Roles in Growth and Puberty.

Authors:  David Garcia-Galiano; Alexandra L Cara; Zachary Tata; Susan J Allen; Martin G Myers; Ernestina Schipani; Carol F Elias
Journal:  J Neurosci       Date:  2020-11-06       Impact factor: 6.167

Review 2.  Kisspeptin and neurokinin B analogs use in gynecological endocrinology: where do we stand?

Authors:  A Szeliga; A Podfigurna; G Bala; B Meczekalski
Journal:  J Endocrinol Invest       Date:  2019-12-14       Impact factor: 4.256

3.  Effects of central and peripheral administration of an acute-phase protein, α-1-acid-glycoprotein, on feed intake and rectal temperature in sheep.

Authors:  Brittany A Gregg; Paxton A Parker; Kathryn M Waller; Liesel G Schneider; Miriam Garcia; Barry Bradford; Joseph A Daniel; Brian K Whitlock
Journal:  J Anim Sci       Date:  2019-12-17       Impact factor: 3.159

4.  Reproduction and beyond, kisspeptin in ruminants.

Authors:  Joseph A Daniel; Chad D Foradori; Brian K Whitlock; James L Sartin
Journal:  J Anim Sci Biotechnol       Date:  2015-05-28

5.  Kisspeptin Modulates Luteinizing Hormone Release and Ovarian Follicular Dynamics in Pre-pubertal and Adult Murrah Buffaloes.

Authors:  Vishalkumar Pottapenjera; Srinivasa R Rajanala; Chandrasekhar Reddy; Arunakumari Gangineni; Kiran Avula; Sandeep K Bejjanki; Sriravali Sathagopam; Surabhi Kesharwani; Sathya Velmurugan
Journal:  Front Vet Sci       Date:  2018-07-04

6.  Kisspeptin receptor agonist (FTM080) increased plasma concentrations of luteinizing hormone in anestrous ewes.

Authors:  Brian K Whitlock; Joseph A Daniel; Lisa L Amelse; Valeria M Tanco; Kelly A Chameroy; F Neal Schrick
Journal:  PeerJ       Date:  2015-11-05       Impact factor: 2.984

7.  Peripheral action of kisspeptin at reproductive tissues-role in ovarian function and embryo implantation and relevance to assisted reproductive technology in livestock: a review.

Authors:  Michael J D'Occhio; Giuseppe Campanile; Pietro S Baruselli
Journal:  Biol Reprod       Date:  2020-12-01       Impact factor: 4.285

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.